Hot on the heels of the announcement of a revolutionary method of creating stem cells without destroying human embryos, the Harvard researchers who discovered the technique are spinning out a company to commercialize it.
Researchers at Boston’s Harvard Stem Cell Institute discovered a way to reprogram human skin cells so that they become stem cells, bypassing the creation of stem cell lines from human embryos.
Research published in the journal Cell Stem Cell details how the team, led by Derrick Rossi, used RNA from stem cells to transform ordinary skin cells into induced pluripotent stem cells. The technique avoids using a virus to carry new genes into the cells — and the controversial destruction of human embryos to derive stem cells.
That technique is at the heart of high-profile legal wrangling between the U.S. government and two researchers who sued to stop federal funding of research using stem cells from embryos. Judge Royce Lamberth of the U.S. District Court for the District of Columbia ruled late in the summer that federal funds could not be used for the the research, derailing scores of projects looking into the causes of diseases like Parkinson’s, Alzheimer’s and cystic fibrosis. President Barack Obama had sought to restore stem cell research funding from constraints imposed under the Bush administration, but Lamberth ruled that the policy violated the Dickey-Wicker Amendment, aimed at stopping the destruction of human embryos. This week a three-judge panel on a federal appeals lifted Lamberth’s injunction barring the funding.
Here’s a video explaining the new technique: